Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/22/1998 | WO1998046245A1 Method and composition for treating sleep apnea |
10/22/1998 | WO1998046241A1 A combination therapy for hiv infections |
10/22/1998 | WO1998046238A1 Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent |
10/22/1998 | WO1998046224A1 Compositions and method for treating bladder dysfunction |
10/22/1998 | WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
10/22/1998 | WO1998046210A1 Method and composition for targeted delivery of compounds |
10/22/1998 | WO1998046209A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
10/22/1998 | WO1998046208A1 Hair follicle dna delivery system |
10/22/1998 | WO1998046083A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
10/22/1998 | WO1998046082A1 Cell-coated supports |
10/22/1998 | WO1998046077A1 A method for treating papillomavirus infections |
10/22/1998 | WO1998036068A3 Human p24 vesicle proteins |
10/22/1998 | WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system |
10/22/1998 | WO1998034949A3 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
10/22/1998 | WO1998031815A3 Subunits of nadh dehydrogenase |
10/22/1998 | WO1998031793A3 Immunomodulating properties, amino acid and nucleotide sequence of colostrum derived growth factor |
10/22/1998 | WO1998002190A3 Cationic amphiphile/dna complexes |
10/22/1998 | DE19749973C1 New T4 lysozyme polypeptide compounds |
10/22/1998 | DE19745792C1 Isolation of wound healing regulatory factors |
10/22/1998 | DE19716167A1 Purification of cyclosporin A and related cyclosporins from crude extract |
10/22/1998 | DE19716154A1 Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren The stable pharmaceutical dosage form of peptides, proteins and nucleic acids |
10/22/1998 | DE19716098A1 Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden Fibroblasts with a foreign gene containing composition for the treatment of wounds |
10/22/1998 | CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
10/22/1998 | CA2706609A1 Osteoprotegerin binding proteins and receptors |
10/22/1998 | CA2293311A1 Synergistic method for treating cancer |
10/22/1998 | CA2291705A1 Receptors for tgf-.beta.-related neurotrophic factors |
10/22/1998 | CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna |
10/22/1998 | CA2288968A1 Permucous preparation |
10/22/1998 | CA2287779A1 Human tumor-associated kazal inhibitor |
10/22/1998 | CA2287526A1 Novel dlg family molecule, polynucleotide encoding the same, antibody against the same, and method for detecting dlg gene |
10/22/1998 | CA2287518A1 A novel th2-specific gene |
10/22/1998 | CA2287450A1 A novel human g-protein coupled receptor |
10/22/1998 | CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e |
10/22/1998 | CA2286934A1 Novel polypeptides within the growth factor superfamily |
10/22/1998 | CA2286877A1 Peptide antiestrogen compositions and methods for treating breast cancer |
10/22/1998 | CA2286859A1 Herpes simplex virus us3 and icp4 as inhibitors of apoptosis |
10/22/1998 | CA2286819A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
10/22/1998 | CA2286798A1 Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
10/22/1998 | CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
10/22/1998 | CA2286580A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
10/22/1998 | CA2286484A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same |
10/22/1998 | CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
10/22/1998 | CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens |
10/22/1998 | CA2286351A1 Extracellular/epidermal growth factor like protein |
10/22/1998 | CA2286332A1 Inhibitors for urokinase receptor |
10/22/1998 | CA2286290A1 Secreted proteins and polynucleotides encoding them |
10/22/1998 | CA2286263A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
10/22/1998 | CA2286137A1 Ngf for the prevention of demyelination in the nervous system |
10/22/1998 | CA2285968A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
10/22/1998 | CA2285940A1 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions |
10/22/1998 | CA2285705A1 Selective factor xa inhibitors |
10/22/1998 | CA2285685A1 Selective factor xa inhibitors |
10/22/1998 | CA2285659A1 Selective factor xa inhibitors |
10/22/1998 | CA2285572A1 A method for treating papillomavirus infections |
10/22/1998 | CA2284832A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use |
10/22/1998 | CA2284726A1 Antagonistic anti-avb3 integrin antibodies |
10/22/1998 | CA2284127A1 Flt3 ligand chimeric proteins |
10/22/1998 | CA2283511A1 Teicoplanin derivatives |
10/22/1998 | CA2283435A1 Deacylation process and product |
10/22/1998 | CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2229428A1 3-dehydroquinate synthase (arob) |
10/21/1998 | EP0872557A1 Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same |
10/21/1998 | EP0872552A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin |
10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
10/21/1998 | EP0872488A1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME |
10/21/1998 | EP0872486A1 Eimeria proteins as vaccines |
10/21/1998 | EP0872245A1 Methods for treating vascular disorders with activated Protein C |
10/21/1998 | EP0871883A1 Compounds and methods related to parathyroid hormone-like protein |
10/21/1998 | EP0871763A1 Method for preparation of type ii collagen |
10/21/1998 | EP0871748A2 Delivery of biologically active polypeptides |
10/21/1998 | EP0871745A1 Aspergillus arabinofuranosidase |
10/21/1998 | EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
10/21/1998 | EP0871732A1 Method of treating sepsis |
10/21/1998 | EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing |
10/21/1998 | EP0871728A2 Targets for breast cancer diagnosis and treatment |
10/21/1998 | EP0871725A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
10/21/1998 | EP0871724A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus |
10/21/1998 | EP0871723A1 Somatic gene therapy to cells associated with fluid spaces |
10/21/1998 | EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
10/21/1998 | EP0871713A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
10/21/1998 | EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof |
10/21/1998 | EP0871705A1 Human ccn-like growth factor |
10/21/1998 | EP0871703A1 Dna encoding glutamate gated chloride channels |
10/21/1998 | EP0871702A1 Cytokine designated lerk-7 |
10/21/1998 | EP0871673A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
10/21/1998 | EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
10/21/1998 | EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
10/21/1998 | EP0871669A1 Human somatostatin-like receptor |
10/21/1998 | EP0871667A1 G-protein coupled receptor |
10/21/1998 | EP0871666A1 Receptor-selective somatostatin analogs |
10/21/1998 | EP0871665A1 Insulin derivatives |
10/21/1998 | EP0871664A1 Novel chemokine for mobilizing stem cells |
10/21/1998 | EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
10/21/1998 | EP0871662A1 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
10/21/1998 | EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins |
10/21/1998 | EP0871660A1 A 12-kda protein derived from m. tuberculosis useful for treatment of autoimmune diseases |
10/21/1998 | EP0871657A1 Methods for treatment and prevention of diabetes |
10/21/1998 | EP0871656A1 Novel dolastatin derivatives, their preparation and use |
10/21/1998 | EP0871655A2 Pcna binding substance |